Identification of human exT
Journal
Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
21
10
2022
accepted:
13
07
2023
pubmed:
11
8
2023
medline:
11
8
2023
entrez:
10
8
2023
Statut:
ppublish
Résumé
In atherosclerosis, some regulatory T (T
Identifiants
pubmed: 37563308
doi: 10.1038/s41590-023-01589-9
pii: 10.1038/s41590-023-01589-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1748-1761Subventions
Organisme : NHLBI NIH HHS
ID : P01 HL136275
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL145241
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Tse, K. et al. Atheroprotective vaccination with MHC-II restricted peptides from ApoB-100. Front. Immunol. 4, 493 (2013).
pubmed: 24416033
pmcid: 3873602
doi: 10.3389/fimmu.2013.00493
Kimura, T. et al. Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells. Am. J. Physiol. 312, H781–H790 (2017).
Kimura, T. et al. Regulatory CD4
pubmed: 29588316
pmcid: 6160361
doi: 10.1161/CIRCULATIONAHA.117.031420
Wolf, D. et al. Pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein B
pubmed: 32703007
pmcid: 7515473
doi: 10.1161/CIRCULATIONAHA.119.042863
Marchini, T., Hansen, S. & Wolf, D. ApoB-specific CD4
pubmed: 33669769
pmcid: 7922692
doi: 10.3390/cells10020446
Roy, P. et al. Immunodominant MHC-II (major histocompatibility complex II) restricted epitopes in human apolipoprotein B. Circ. Res. 131, 258–276 (2022).
pubmed: 35766025
pmcid: 9536649
doi: 10.1161/CIRCRESAHA.122.321116
Saigusa, R. et al. Single-cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. Nat. Cardiovasc. Res. 1, 462–475 (2022).
pubmed: 35990517
pmcid: 9383695
doi: 10.1038/s44161-022-00063-3
Ait-Oufella, H., Lavillegrand, J.-R. & Tedgui, A. Regulatory T cell-enhancing therapies to treat atherosclerosis. Cells 10, 723 (2021).
pubmed: 33805071
pmcid: 8064079
doi: 10.3390/cells10040723
Roy, P., Orecchioni, M. & Ley, K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat. Rev. Immunol. 22, 251–265 (2022).
pubmed: 34389841
doi: 10.1038/s41577-021-00584-1
Li, J. et al. CCR5
pubmed: 27021296
pmcid: 4867125
doi: 10.1161/CIRCRESAHA.116.308648
Butcher, M. J. et al. Atherosclerosis-driven T
pubmed: 27635087
pmcid: 5242312
doi: 10.1161/CIRCRESAHA.116.309764
Qiu, R. et al. Regulatory T cell plasticity and stability and autoimmune diseases. Clin. Rev. Allergy Immunol. 58, 52–70 (2020).
pubmed: 30449014
doi: 10.1007/s12016-018-8721-0
Ali, A. J., Makings, J. & Ley, K. Regulatory T cell stability and plasticity in atherosclerosis. Cells 9, 2665 (2020).
pubmed: 33322482
pmcid: 7764358
doi: 10.3390/cells9122665
Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000–1007 (2009).
pubmed: 19633673
pmcid: 2729804
doi: 10.1038/ni.1774
Bailey-Bucktrout, S. L. et al. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39, 949–962 (2013).
pubmed: 24238343
pmcid: 3912996
doi: 10.1016/j.immuni.2013.10.016
Svensson, M. N. D. et al. Reduced expression of phosphatase PTPN2 promotes pathogenic conversion of T
pubmed: 30620725
pmcid: 6391091
doi: 10.1172/JCI123267
Gaddis, D. E. et al. Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis. Nat. Commun. 9, 1095 (2018).
pubmed: 29545616
pmcid: 5854619
doi: 10.1038/s41467-018-03493-5
Hsieh, W.-C. et al. PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis. JCI Insight 5, e141868 (2020).
pubmed: 33055428
pmcid: 7605542
doi: 10.1172/jci.insight.141868
Hua, J. et al. Pathological conversion of regulatory T cells is associated with loss of allotolerance. Sci. Rep. 8, 7059 (2018).
pubmed: 29728574
pmcid: 5935752
doi: 10.1038/s41598-018-25384-x
Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667–1671 (2010).
pubmed: 20929851
pmcid: 4262151
doi: 10.1126/science.1191996
Saigusa, R. et al. Sex differences in coronary artery disease and diabetes revealed by scRNA-seq and CITE-seq of human CD4
pubmed: 36077273
pmcid: 9456056
doi: 10.3390/ijms23179875
Glanville, J. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 547, 94–98 (2017).
pubmed: 28636589
pmcid: 5794212
doi: 10.1038/nature22976
Dogra, P. et al. Tissue determinants of human NK cell development, function, and residence. Cell 180, 749–763 (2020).
pubmed: 32059780
pmcid: 7194029
doi: 10.1016/j.cell.2020.01.022
Ferraro, A. et al. Interindividual variation in human T regulatory cells. Proc. Natl Acad. Sci. USA 111, E1111–E1120 (2014).
pubmed: 24610777
pmcid: 3970507
doi: 10.1073/pnas.1401343111
Sokol, C. L. & Luster, A. D. The chemokine system in innate immunity. Cold Spring Harb. Perspect. Biol. 7, a016303 (2015).
pubmed: 25635046
pmcid: 4448619
doi: 10.1101/cshperspect.a016303
Mackay, C. R. CXCR3
pubmed: 25180533
pmcid: 4151222
doi: 10.1172/JCI77837
Khaw, Y. M. et al. Astrocytes lure CXCR2-expressing CD4
pubmed: 33597297
pmcid: 7923593
doi: 10.1073/pnas.2017213118
Weiskopf, D. et al. Dengue virus infection elicits highly polarized CX3CR1
pubmed: 26195744
pmcid: 4534238
doi: 10.1073/pnas.1505956112
Stolla, M. et al. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1. PLoS ONE 7, e43572 (2012).
pubmed: 22916279
pmcid: 3423360
doi: 10.1371/journal.pone.0043572
Lesnik, P., Haskell, C. A. & Charo, I. F. Decreased atherosclerosis in CX3CR1
pubmed: 12569158
pmcid: 151849
doi: 10.1172/JCI15555
Abi-Younes, S. et al. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ. Res. 86, 131–138 (2000).
pubmed: 10666407
doi: 10.1161/01.RES.86.2.131
Shevach, E. M. Foxp3
pubmed: 29868011
pmcid: 5962663
doi: 10.3389/fimmu.2018.01048
Klein, L., Robey, E. A. & Hsieh, C.-S. Central CD4
pubmed: 30420705
doi: 10.1038/s41577-018-0083-6
Cording, S. et al. The intestinal micro-environment imprints stromal cells to promote efficient T
pubmed: 23945546
doi: 10.1038/mi.2013.54
Pezoldt, J. et al. Neonatally imprinted stromal cell subsets induce tolerogenic dendritic cells in mesenteric lymph nodes. Nat. Commun. 9, 3903 (2018).
pubmed: 30254319
pmcid: 6156403
doi: 10.1038/s41467-018-06423-7
Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector T
pubmed: 16648838
doi: 10.1038/nature04753
Korn, T. et al. IL-6 controls T
pubmed: 19015529
pmcid: 2587589
doi: 10.1073/pnas.0809850105
Josefowicz, S. Z., Lu, L.-F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–564 (2012).
pubmed: 22224781
pmcid: 6066374
doi: 10.1146/annurev.immunol.25.022106.141623
Josefowicz, S. Z. et al. Extrathymically generated regulatory T cells control mucosal T
pubmed: 22318520
pmcid: 3485072
doi: 10.1038/nature10772
Chaudhry, A. et al. CD4
pubmed: 19797626
pmcid: 4408196
doi: 10.1126/science.1172702
Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T
pubmed: 19182775
pmcid: 2864791
doi: 10.1038/nature07674
Koch, M. A. et al. T-bet
pubmed: 22960221
pmcid: 3501343
doi: 10.1016/j.immuni.2012.05.031
Wang, Z. et al. Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis. Nat. Cardiovasc. Res. 2, 290–306 (2023).
pubmed: 37621765
pmcid: 10448629
doi: 10.1038/s44161-023-00218-w
Depuydt, M. A. C. et al. Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells. Nat. Cardiovasc. Res. 2, 112–125 (2023).
doi: 10.1038/s44161-022-00208-4
Fisson, S. et al. Continuous activation of autoreactive CD4
pubmed: 12939344
pmcid: 2194185
doi: 10.1084/jem.20030686
Chowdhury, R. R. et al. Human coronary plaque T cells are clonal and cross-react to virus and self. Circ. Res. 130, 1510–1530 (2022).
pubmed: 35430876
pmcid: 9286288
doi: 10.1161/CIRCRESAHA.121.320090
Thome, J. J. C. & Farber, D. L. Emerging concepts in tissue-resident T cells: lessons from humans. Trends Immunol. 36, 428–435 (2015).
pubmed: 26072286
pmcid: 4491028
doi: 10.1016/j.it.2015.05.003
Van Acker, H. H., Capsomidis, A., Smits, E. L. & Van Tendeloo, V. F. CD56 in the immune system: more than a marker for cytotoxicity? Front. Immunol. 8, 892 (2017).
pubmed: 28791027
pmcid: 5522883
doi: 10.3389/fimmu.2017.00892
Sharma, M. D. et al. An inherently bifunctional subset of Foxp3
pubmed: 23684987
pmcid: 3681093
doi: 10.1016/j.immuni.2013.01.013
Sharma, M. D. et al. Reprogrammed foxp3
pubmed: 21145762
pmcid: 3032429
doi: 10.1016/j.immuni.2010.11.022
Rosales, S. L. et al. A sensitive and integrated approach to profile messenger RNA from samples with low cell numbers. Methods Mol. Biol. 1799, 275–302 (2018).
pubmed: 29956159
doi: 10.1007/978-1-4939-7896-0_21
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886
doi: 10.1093/bioinformatics/bts635
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281
pmcid: 4302049
doi: 10.1186/s13059-014-0550-8
Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
Subramanian, A. et al. Gene-set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
pubmed: 16199517
pmcid: 1239896
doi: 10.1073/pnas.0506580102
Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194–1202 (2020).
pubmed: 32341563
pmcid: 7541396
doi: 10.1038/s41587-020-0505-4